ARS Pharmaceuticals launches Neffy, a breakthrough nasal spray, while insider selling is concerning. Read why SPRY stock has ...

on strong demand for its research and analytics products. Growing expectations of a soft landing for the U.S. economy as the Federal Reserve began its rate cut cycle in September have spurred ...

Harley's traditional focus on heavyweight bikes could reduce the demand for the firm's products as consumer ... thinking of our people and exacting analysis of our research processes.

Ansys beat Wall Street expectations for third-quarter revenue and profit on Wednesday, helped by growing demand for its ...